Interactions between human complement components factor H, factor I and C3b

被引:68
作者
Soames, CJ [1 ]
Sim, RB [1 ]
机构
[1] UNIV OXFORD,DEPT BIOCHEM,MRC,IMMUNOCHEM UNIT,OXFORD OX1 3QU,ENGLAND
关键词
D O I
10.1042/bj3260553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using a microtitre plate assay, direct binding between complement factors I and H was demonstrated, and ligand blotting indicated that factor H interacts with the heavy chain of factor I. Similarly, direct C3(NH3)-factor I and C3(NH3)-factor H binding was characterized [where C3(NK3) is a form of C3 that is cleaved by factor I in the presence of factor H]. Both factor H and factor I interacted with both chains of C3(NH3) and blotting. Binding reactions between all three pairs of components were highly dependent on ionic strength, and showed similar pH optima. Binding assays with all three components present led to the following conclusions. (a) Binding sites for C3(NH3) and factor I on factor H do not overlap, and binding of factor I and C3(NH3) to soluble factor H promotes the weak factor I-C3(NH3) interaction. (b) Anomalies arise with immobilized factor H, which may be artefactual or may reflect the physiological situation. (c) Similarly, binding sites on factor I for C3(NH3) factor H do not overlap, and binding of factor H and C3(NH3)r I promotes direct factor H-C3(NH3) interactions. Based on these results, a model of the interactions between factor H, factor I and C3(NH3) leading to the processing of C3(NH3) is proposed.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 48 条
[1]   STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE COMPLEMENT COMPONENT FACTOR-H WITH THE USE OF DIFFERENT ENZYMES AND MONOCLONAL-ANTIBODIES TO FACTOR-H [J].
ALSENZ, J ;
SCHULZ, TF ;
LAMBRIS, JD ;
SIM, RB ;
DIERICH, MP .
BIOCHEMICAL JOURNAL, 1985, 232 (03) :841-850
[2]   SOLUTION STRUCTURE OF A PAIR OF COMPLEMENT MODULES BY NUCLEAR-MAGNETIC-RESONANCE [J].
BARLOW, PN ;
STEINKASSERER, A ;
NORMAN, DG ;
KIEFFER, B ;
WILES, AP ;
SIM, RB ;
CAMPBELL, ID .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (01) :268-284
[3]  
BARLOW PN, 1992, BIOCHEMISTRY-US, V31, P3636
[4]   SEGMENT SPANNING RESIDUES-727-768 OF THE COMPLEMENT-C3 SEQUENCE CONTAINS A NEOANTIGENIC SITE AND ACCOMMODATES THE BINDING OF CR-1, FACTOR-H, AND FACTOR-B [J].
BECHERER, JD ;
ALSENZ, J ;
ESPARZA, I ;
HACK, CE ;
LAMBRIS, JD .
BIOCHEMISTRY, 1992, 31 (06) :1787-1794
[5]   READY FOR A MOTIF SUBMISSION - A PROPOSED CHECKLIST [J].
BORK, P ;
OUZOUNIS, C ;
MCENTYRE, J .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (03) :104-104
[6]   CHARACTERIZATION OF THE PRIMARY AMINO-ACID-SEQUENCE OF HUMAN-COMPLEMENT CONTROL PROTEIN FACTOR-I FROM AN ANALYSIS OF CDNA CLONES [J].
CATTERALL, CF ;
LYONS, A ;
SIM, RB ;
DAY, AJ ;
HARRIS, TJR .
BIOCHEMICAL JOURNAL, 1987, 242 (03) :849-856
[7]   PURIFICATION OF THE HUMAN-COMPLEMENT CONTROL PROTEIN C3B INACTIVATOR [J].
CROSSLEY, LG ;
PORTER, RR .
BIOCHEMICAL JOURNAL, 1980, 191 (01) :173-182
[8]   STRUCTURAL CHARACTERIZATION OF FACTOR-I MEDIATED CLEAVAGE OF THE 3RD COMPONENT OF COMPLEMENT [J].
DAVIS, AE ;
HARRISON, RA .
BIOCHEMISTRY, 1982, 21 (23) :5745-5749
[9]   INHIBITORY EFFECT OF ZN-2+ IONS ON THE DEGRADATION OF THE COMPLEMENT ACTIVATION FRAGMENT C3B [J].
DAY, AJ ;
SIM, RB .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (01) :73-74
[10]  
DAY AJ, 1991, J BIOMED SCI, V1, P153